- $15.07bn
- $14.68bn
- $1.86bn
- 83
- 25
- 100
- 78
Annual income statement for Nutanix, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2019 July 31st | 2020 July 31st | R2021 July 31st | R2022 July 31st | 2023 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,236 | 1,308 | 1,394 | 1,581 | 1,863 |
| Cost of Revenue | |||||
| Gross Profit | 932 | 1,021 | 1,102 | 1,260 | 1,531 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,834 | 2,137 | 2,056 | 2,105 | 2,059 |
| Operating Profit | -598 | -829 | -662 | -524 | -196 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -613 | -855 | -1,017 | -780 | -234 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -621 | -873 | -1,036 | -799 | -255 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -621 | -873 | -1,036 | -799 | -255 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -621 | -873 | -1,036 | -799 | -255 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.43 | -4.47 | -5 | -3.4 | -0.963 |